Martin Moore

Martin Moore is an Adjunct Professor in both the Division of Infectious Disease and the Department of Pediatrics at the Emory University School of Medicine. He also holds the title of Research Scholar at Children’s Healthcare of Atlanta and directs the Moore Lab at the Pediatric Research Alliance. Moore’s work focuses on Respiratory Syncytial Virus, the cause of many debilitating respiratory illnesses and for which no vaccines or antiviral therapies currently exist. Moore studies the molecular mechanisms at work in RSV pathogenesis with the aim of developing vaccines and treatments. Over his career, he has authored 30 patents and founded his own biotechnology startup, Meissa Vaccines, which he also manages as CEO.


Novel Tool for Respiratory Syncytial Virus (RSV) Vaccine Development & Research
Respiratory Syncytial Virus (RSV) Fluorescent Reporter Strain
Respiratory Syncytial Virus (RSV) Luminescent Reporter Strain
Respiratory syncytial virus (RSV) Reporter Plasmid for High Throughput Drug Screening
Respiratory Syncytial Virus (RSV) A/2001/2-20 Strain with Enhanced Pathogenesis
Untagged RSV A2-line 19F Strain Generated from BAC-RSV Clone
Novel Vaccine Antigen Presentation Platforms
Recombinant Respiratory Syncytial Viruses (RSVs) Expressing the G and F Proteins from Various Strains
Recombinant RSV Strains Expressing Renilla Luciferase and G & F Proteins
Broad Spectrum Vaccine to Human Rhinovirus Serotypes
Recombinant Respiratory Syncytial Virus (RSV) Firefly Luciferase Reporter Strain
Plasmid for Respiratory Syncytial Virus (RSV) Vaccine Development & Research
Helper Plasmids for Rescue of Respiratory Syncytial Virus
Respiratory Syncytial Virus (RSV) A2 Expressing Firefly Luciferase
Respiratory Syncytial Virus Strain A2-2-20F
Drug Discovery
Medical Device
Micro and Nanotechnology
Research Tools